Search Records

Drugs and vaccines that have been authorized by Health Canada for use in relation to the COVID-19 pandemic are listed here.

This Points to Consider document lays out a regulatory approach for updating authorised coronavirus vaccines should mutations at any time make them less efficacious due to insufficient cross-reactivity.

Sponsors of COVID-19-related drug and vaccine clinical trials can choose between 2 different processes: existing process outlined in the Food and Drug Regulations or process outlined in the new interim order for clinical trials for medical devices and drugs related to COVID-19.

Initial supplies of authorized COVID-19 vaccines are not expected to be sufficient to offer vaccination to all Canadians in whom they are authorized for use until the fall of 2021. Therefore, recommendations to prioritize key populations for early immunization are needed in order to meet the...

COVID-19 vaccines are safe and effective. Free vaccines will be available to everyone who lives in Canada over the course of 2021. Until extensive immunization is achieved, public health measures will continue to be essential to minimize the spread of COVID-19 in Canada and save lives.

FluWatch is Canada's national surveillance system that monitors the spread of influenza and influenza-like illnesses on an ongoing basis. FluWatch reports, posted every Friday, contain information on flu activity in Canada. The FluWatch program consists of a network of labs, hospitals, doctor's...

Vaccines are the most effective way to prevent the spread of infectious disease, but developing one can be costly, long, and complex. A safe and effective vaccine will bring us one step closer to the widespread and long-term management of COVID-19.

The purpose of this document is to assist in planning immunization clinics for COVID-19 vaccines during the COVID-19 pandemic.

Immunizing all Canadians with COVID-19 vaccine in a timely way will be a major challenge. In support of this massive undertaking, the Public Health Agency of Canada (PHAC) has developed planning guidance for the administration of COVID-19 vaccine.

The Government of Canada has established a number of advisory groups and task forces composed of stakeholders from the public sector, private sector and/or academia and research community, to provide recommendations or actions to address the COVID-19 pandemic in Canada.